Evaluation of the quality of life dynamics in comorbid patients with hip and knee joint arthroplasty

Abstract

BACKGROUND: In recent years, in traumatology and orthopedics, statistical methods of survival analysis have been used to assess long-term treatment results, which make it possible to take into account censored clinical observations. This method of statistical analysis allows to take into account both cases of attrition from care and cases of incomplete follow-ups. There is no concurrent point of view on the dependence of the long-term results of hip and knee arthroplasty on the comorbidity of a patient. This circumstance fosters a special study using survival analysis.

AIM: To study the long-term results of total hip and knee arthroplasty in the patients with osteoarthritis. To determine the patients’ quality of life depending on the presence of pronounced concomitant pathology.

MATERIALS AND METHODS: The groups of patients with comorbidity and without significant concomitant pathology have been compared. The first group included 806 patients aged 19 to 88 years who underwent primary total hip replacement in the Clinic of Traumatology and Orthopedics of the North-Western State Medical University named after I.I. Mechnikov from 2014 to 2018 in connection with osteoarthritis. The second group consisted of 376 patients aged 43 to 85 years who underwent primary total KR due to osteoarthritis in the V.A. Baranov Republican Hospital (Petrozavodsk) in 2016–2019. Statistical data processing and graph design have been carried out with R programming language with open access via https://cran.r-project.org. The probability of maintaining a satisfactory assessment of the quality of life by a certain observation point t (year of observation) has been assessed using the Kaplan–Mayer method. The logrank test has been used in order to compare the probability of maintaining a satisfactory assessment of quality of life during the entire follow-up period in the groups of patients with and without polymorbidity.

RESULTS: At the end of the 5th year of follow-up, the probability of maintaining excellent and good quality of life after hip replacement with a 95% confidence interval was 0.88 (0.81; 0.94) in the patients without comorbidity, 0.84 (0.79; 0.88) in the patients with severe concomitant pathology. Test statistics (Z = 0.93) and p = 0.31 indicate statistically insignificant differences in survival curves between the groups of patients with varying degrees of comorbidity.

When analyzing the five-year results of the knee replacement, the quality of life among patients with high and low comorbidity did not differ significantly. The probability of excellent and good quality of life at the 5th year of follow-up in practically healthy patients and in cases of mild therapeutic disease was 0.78 (0.67; 0.88); with a high degree of comorbidity — 0.74 (0.65; 0.81).

CONCLUSIONS: By the end of the 5th year of follow-up of the patients who have undergone hip or knee replacement due to osteoarthritis, an excellent and good quality of life can be expected on average in 80% of the patients. Satisfactory and unsatisfactory — in 20% of the patients. Excellent and good quality of life 5 years after hip or knee arthroplasty in the patients with severe comorbidity does not significantly differ from that in the practically healthy patients without comorbidity (p > 0,05).

Keywords

osteoarthritis / polymorbidity / hip replacement / knee replacement / long-term results / quality of life / survival analysis

References

[1] Logvinov NL, Khoroshkov SN, Yarygin NV. Analysis of the results of total knee re-placement according to 18-year-old data from the Australian register AOANJRR. Department of Traumatology and Orthopedics. 2020;(2(40)):44–59. (In Russ.) DOI: 10.17238/issn2226-2016.2020.2.44-59

[2] Логвинов Н.Л., Хорошков С.Н., Ярыгин Н.В. Анализ результатов тотального эндопротезирования коленного сустава по 18-летним данным австралийского регистра AOANJRR // Кафедра травматологии и ортопедии. 2020. № 2(40). С. 44–59. DOI: 10.17238/issn2226-2016.2020.2.44-59

[3] Vorokov AA, Tkachenko AN, Khromov AA, Khaydarov VM. Hip replacement: de-termination of indications for surgery (scientific review). Medical Pharmaceutical Journal Pulse. 2020;22(6):40–50. (In Russ.) DOI: 10.26787/nydha-2686-6838-2020-22-6-40-50

[4] Вороков А.А., Ткаченко А.Н., Хромов А.А., Хайдаров В.М. Эндопротезирование тазобедренного сустава: определение показаний к операции (научный обзор) // Медико-фармацевтический журнал Пульс. 2020. Т. 22, № 6. С.40–50. DOI: 10.26787/nydha-2686-6838-2020-22-6-40-50

[5] Dabare C, Le Marshall K, Leung A, et al. Differences in presentation, progression and rates of arthroplasty between hip and knee osteoarthritis: Observations from an osteoarthritis cohort study — a clear role for conservative management. Int J Rheum Dis. 2017;20(10):1350–1360. DOI: 10.1111/1756-185X.13083

[6] Dabare C., Le Marshall K., Leung A. et al. Differences in presentation, progression and rates of arthroplasty between hip and knee osteoarthritis: Observations from an osteoarthritis cohort study — a clear role for conservative management // Int. J. Rheum. Dis. 2017. Vol. 20, No. 10. P. 1350–1360. DOI: 10.1111/1756-185X.13083

[7] Goryanaya NA, Ishekova NI, Popov VV, Bondarenko EG. Changing the quality of life of patients after hip replacement at the first stage of rehabilitation. Human ecology. 2017;(1):41–44. (In Russ.)

[8] Горянная Н.А., Ишекова Н.И., Попов В.В., Бондаренко Е.Г. Изменение качества жизни пациентов после эндопротезирования тазобедренного сустава на первом этапе реабилитации // Экология человека. 2017. № 1. С. 41–44.

[9] Aldinger PR, Jung AW, Pritsch M, et al. Uncemented grit-blasted straight tapered titanium stems in patients younger than fifty-five years of age: fifteen to twenty-year results. J Bone Joint Surg Am. 2009;91(6):1432–1439. DOI: 10.2106/JBJS.H.00297

[10] Aldinger P.R., Jung A.W., Pritsch M. et al. Uncemented grit-blasted straight tapered titanium stems in patients younger than fifty-five years of age: fifteen to twenty-year results // J. Bone Joint. Surg. Am. 2009. Vol. 91, No. 6. Р. 1432–1439. DOI: 10.2106/JBJS.H.00297

[11] Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–785. DOI: 10.2106/JBJS.F.00222

[12] Kurtz S., Ong K., Lau E. et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 // J. Bone Joint. Surg. Am. 2007. Vol. 89, No. 4. P. 780–785. DOI: 10.2106/JBJS.F.00222

[13] Świtoń A, Wodka-Natkaniec E, Niedźwiedzki Ł, et al. Activity and quality of life after total hip arthroplasty. Ortop Traumatol Rehabil. 2017;19(5):441–450. DOI: 10.5604/01.3001.0010.5823

[14] Świtoń A., Wodka-Natkaniec E., Niedźwiedzki Ł. et al. Activity and quality of life after total hip arthroplasty // Ortop. Traumatol. Rehabil. 2017. Vol. 19, No. 5. P. 441–450. DOI: 10.5604/01.3001.0010.5823

[15] Flecher X, Sporer S, Paprosky W. Management of severe bone loss in acetabular revision using a trabecular metal shell. J Arthroplasty. 2008;23(7):949–955. DOI: 10.1016/j.arth.2007.08.019

[16] Flecher X., Sporer S., Paprosky W. Management of severe bone loss in acetabular revision using a trabecular metal shell // J. Arthroplasty. 2008. Vol. 23, No. 7. P. 949–955. DOI: 10.1016/j.arth.2007.08.019

[17] Korneenkov AA, Fanta IV, Vyazemskaya EE. Assessment of the dynamics of disease symptoms by methods of survival analysis. Russian otorhinolaryngology. 2019;18(4(101)):8–14. (In Russ.) DOI: 10.18692/1810-4800-2019-4-8-14

[18] Корнеенков А.А., Фанта И.В., Вяземская Е.Э. Оценка динамики симптомов болезни методами анализа выживаемости // Российская оториноларингология. 2019. Т. 18, № 4(101). С. 8–14. DOI: 10.18692/1810-4800-2019-4-8-14

[19] Korneenkov AA, Fanta IV. Assessment of the size of the effect of clinical impact in otorhinolaryngology. Russian otorhinolaryngology. 2020;19(2(105)):42–50. (In Russ.) DOI: 10.18692/1810-4800-2020-2-42-50

[20] Корнеенков А.А., Фанта И.В. Оценка размера эффекта клинического воздействия в оториноларингологии // Российская оториноларингология. 2020. Т. 19, № 2(105). С. 42–50. DOI: 10.18692/1810-4800-2020-2-42-50

[21] Tkachenko AN, Korneenkov AA, Dorofeev YuL, et al. Assessment of the dynamics of quality of life by methods of survival analysis in patients undergoing hip arthroplasty. Orthopaedic Genius. 2021;27(5):527–531. (In Russ.) DOI: 10.18019/1028-4427-2021-27-5-527-531

[22] Ткаченко А.Н., Корнеенков А.А., Дорофеев Ю.Л. и др. Оценка динамики качества жизни методами анализа выживаемости у пациентов, перенесших артропластику тазобедренного сустава // Гений ортопедии. 2021. Т. 27, № 5. С. 527–531. DOI: 10.18019/1028-4427-2021-27-5-527-531

[23] Fonturenko AYu, Bashkinov RA, Mazurov VI, et al. Comorbid pathology in patients with gouty arthritis according to the city register of St. Petersburg for 2000-2019. Russian Medical Inquiry. 2020;4(8):475–482. (In Russ.) DOI: 10.32364/2587-6821-2020-4-8-475-482

[24] Фонтуренко А.Ю., Башкинов Р.А., Мазуров В.И. и др. Коморбидная патология у пациентов с подагрическим артритом по данным городского регистра Санкт-Петербурга за 2000–2019 гг. // РМЖ. Медицинское обозрение. 2020. Т. 4, № 8. С. 475–482. DOI: 10.32364/2587-6821-2020-4-8-475-482

[25] Mazurov VI, Gaidukova IZ, Bashkinov RA, et al. The effect of asymptomatic hyperu-ricemia on the course of comorbid pathology in patients with osteoarthritis and the possibility of its correction. RMJ. 2021;29(6):56–62. (In Russ.)

[26] Мазуров В.И., Гайдукова И.З., Башкинов Р.А. и др. Влияние бессимптомной гиперурикемии на течение коморбидной патологии у пациентов с остеоартритом и возможности ее коррекции // РМЖ. 2021. Т. 29, № 6. С. 56–62.

[27] Andersen P, Keiding N. Survival analysis, overview. In: Encyclopedia of Statistical Sciences. 2014. P. 4452–4461. DOI: 10.1002/0471667196.ess7225

[28] Andersen P., Keiding N. Survival analysis, overview // Encyclopedia of Statistical Sciences. 2014. P. 4452–4461. DOI: 10.1002/0471667196.ess7225

[29] Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. JASA. 1958;53(282):457–481. DOI: 10.1080/01621459.1958.10501452

[30] Kaplan E.L., Meier P. Nonparametric Estimation from Incomplete Observations // JASA. 1958. Vol. 53, No. 282. P. 457–481. DOI: 10.1080/01621459.1958.10501452

[31] Bland JM, Altman DG. The logrank test. BMJ. 2004;328(7447):1073. DOI: 10.1136/bmj.328.7447.1073

[32] Bland J.M., Altman D.G. The logrank test // BMJ. 2004. Vol. 328, No. 7447. P. 1073. DOI: 10.1136/bmj.328.7447.1073

[33] Kaminsky AV, Marchenkova LO, Pozdnyakov AV. Revision hip replacement: epidemiology, causes, risk factors (review of foreign literature). Bulletin of Traumatology and Orthopedics named after N.N. Priorov. 2015;(2):83–89. (In Russ.) DOI: 10.17816/vto201522283-89

[34] Каминский А.В., Марченкова Л.О., Поздняков А.В. Ревизионное эндопротезирование тазобедренного сустава: эпидемиология, причины, факторы риска (обзор зарубежной литературы) // Вестник травматологии и ортопедии им. Н.Н. Приорова. 2015. № 2. С. 83–89. DOI: 10.17816/vto201522283-89

[35] Prokhorenko VM, Azizov MZh, Shakirov HH. Revision hip replacement: a case-control study. Modern problems of science and education. 2016;6:129. (In Russ.)

[36] Прохоренко В.М., Азизов М.Ж., Шакиров Х.Х. Ревизионное эндопротезирование тазобедренного сустава: исследование «случай-контроль» // Современные проблемы науки и образования. 2016. № 6. С. 129.

[37] Hawker G, Bohm ER, Conner-Spady B. Perspectives of Canadian stakeholders on criteria for appropriateness for total joint arthroplasty in patients with hip and knee osteoarthritis. Arthritis Rheumatol. 2015;67(7):1806–1815. DOI: 10.1002/art.39124

[38] Hawker G., Bohm E.R., Conner-Spady B. Perspectives of Canadian stakeholders on criteria for appropriateness for total joint arthroplasty in patients with hip and knee osteoarthritis // Arthritis Rheumatol. 2015. Vol. 67, No. 7. Р. 1806–1815. DOI: 10.1002/art.39124

[39] Paxton EW, Inacio MC, Khatod M. Risk calculators predict failures of knee and hip arthroplasties: Findings from a large health maintenance organization. Clin Orthop Relat Res. 2015;473(12):3965–3973. DOI: 10.1007/s11999-015-4506-4

[40] Paxton E.W., Inacio M.C., Khatod M. Risk calculators predict failures of knee and hip arthroplasties: Findings from a large health maintenance organization // Clin. Orthop. Relat. Res. 2015. Vol. 473, No. 12. Р. 3965–3973. DOI: 10.1007/s11999-015-4506-4

[41] Lungu E, Maftoon S, Vendittoli PA, Desmeules F. A systematic review of preoperative determinants of patient-reported pain and physical function up to 2 years following primary unilateral total hip arthroplasty. Orthop Traumatol Surg Res. 2016;102(3):397–403. DOI: 10.1016/j.otsr.2015.12.025

[42] Lungu E., Maftoon S., Vendittoli P.A., Desmeules F. A systematic review of preoperative determinants of patient-reported pain and physical function up to 2 years following primary unilateral total hip arthroplasty // Orthop. Traumatol. Surg. Res. 2016. Vol. 102, No. 3. P. 397–403. DOI: 10.1016/j.otsr.2015.12.025

[43] Ibarra Melogno S, Chifflet L, Rey R, et al. Long-term results of hip arthroplasty in patients on dialysis for chronic renal failure. Mortality and implant survival in the National Registry of Uruguay since 2000. Rev Esp Cir Ortop Traumatol (Engl Ed). 2019;63(3):187–191. DOI: 10.1016/j.recot.2018.12.002

[44] Ibarra Melogno S., Chifflet L., Rey R. et al. Long-term results of hip arthroplasty in patients on dialysis for chronic renal failure. Mortality and implant survival in the National Registry of Uruguay since 2000 // Rev. Esp. Cir. Ortop. Traumatol. (Engl Ed). 2019. Vol. 63, No. 3. P. 187–191. DOI: 10.1016/j.recot.2018.12.002

[45] Hofstede SN, Gademan MG, Vliet Vliela TP, et al. Preoperative predictors for outcomes after total hip replacement in patients with osteoarthritis: a systematic review. BMC Musculoskelet Disord. 2016;17:212. DOI: 10.1186/s12891-016-1070-3

[46] Hofstede S.N., Gademan M.G., Vliet Vlieland T.P. et al. Preoperative predictors for outcomes after total hip replacement in patients with osteoarthritis: a systematic review // BMC Musculoskelet. Disord. 2016. Vol. 17. P. 212. DOI: 10.1186/s12891-016-1070-3

[47] Judge A, Javaid MK, Arden NK, et al. Clinical tool to identify patients who are most likely to achieve long-term improvement in physical function after total hip arthroplasty. Arthritis Care Res (Hoboken). 2012;64(6):881–889. DOI: 10.1002/acr.21594

[48] Judge A., Javaid M.K., Arden N.K. et al. Clinical tool to identify patients who are most likely to achieve long-term improvement in physical function after total hip arthroplasty // Arthritis Care Res. (Hoboken). 2012. Vol. 64, No. 6. P. 881–889. DOI: 10.1002/acr.21594

[49] Maempel JF, Riddoch F, Calleja N, Brenkel IJ. Longer hospital stay, more complications, and increased mortality but substantially improved function after knee replacement in older patients. Acta Orthop. 2015;86(4):451–456. DOI: 10.3109/17453674.2015.1040304

[50] Maempel J.F., Riddoch F., Calleja N., Brenkel I.J. Longer hospital stay, more complications, and increased mortality but substantially improved function after knee replacement in older patients // Acta Orthop. 2015. Vol. 86, No. 4. Р. 451–456. DOI: 10.3109/17453674.2015.1040304

[51] Kuperman EF, Schweizer M, Joy P, et al. The effects of advanced age on primary total knee arthroplasty: a meta-analysis and systematic review. BMC Geriatr. 2016;16:41. DOI: 10.1186/s12877-016-0215-4

[52] Kuperman E.F., Schweizer M., Joy P. et al. The effects of advanced age on primary total knee arthroplasty: a meta-analysis and systematic review // BMC Geriatr. 2016. Vol. 16. Р. 41. DOI: 10.1186/s12877-016-0215-4

RIGHTS & PERMISSIONS

Eco-Vector